Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Tuberous Sclerosis 4Seizures 3Lennox Gastaut Syndrome 3Epilepsies, Myoclonic 3Anxiety Disorders 2Tuberous Sclerosis 2 1Tuberous Sclerosis 1 1Spasms, Infantile 1Prostatic Neoplasms 1Parasomnias 1Pain 1Neoplasms 1Nausea 1Marijuana Abuse 1Liver Cirrhosis 1Glioblastoma 1Epilepsy 1Colorectal Neoplasms 1Colonic Neoplasms 1Chemotherapy-Induced Peripheral Neuropathy 1Carcinoma, Intraductal, Noninfiltrating 1Cancer Pain 1Breast Neoplasms 1Breast Carcinoma In Situ 1Behavior 1

Interventions

Music Therapy 7Cognitive Behavioral Therapy 6Surveys and Questionnaires 4Standard of Care 4Saline Solution 4Hypnosis 4Esketamine 4Therapeutics 3Psilocybin 3Palliative Care 2Methods 2Cannabidiol 2Art Therapy 2nabiximols 1Waiting Lists 1Videotape Recording 1Transcutaneous Electric Nerve Stimulation 1Transcranial Direct Current Stimulation 1Timbre Perception 1Sertraline 1Self-Help Groups 1Selective Serotonin Reuptake Inhibitors 1Respiration 1Relaxation Therapy 1Referral and Consultation 1Psychotherapy 1Psychosocial Intervention 1Psychiatric Rehabilitation 1Population Groups 1Pharmaceutical Preparations 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Anxiety Disorders × Cannabidiol × 1 year × Clear all
NCT03948074 2025-09-10

CAFCARS

British Columbia Cancer Agency

Phase 2 Completed
91 enrolled

Anxiety Disorders, Nausea, Pain, Parasomnias

NCT04482244 2025-07-29

RCT of CBD for Anxiety in Advanced Breast Cancer

Dana-Farber Cancer Institute

Phase 2 Active not recruiting
60 enrolled 11 charts

Anxiety Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡